The present scientific marvel was not an accident. Significant advances in AI and machine learning, corporate investments in these technologies, and a research background based on decades of US government support in medical sciences and biotechnology made this possible. The biotechnology sector is undergoing a transformation, and the US government should take strong steps now to recognize the significant impact AI will have on the sector’s entire capacity and ensuring the US remains at the forefront of the impending biotechnology revolution. While the biotechnology revolution is still early and US authority is still in control, the US should realize the linked structure of these innovations.
The Crossroads of Special Operations